Breaking News

Dollar Tree Agrees to Buy Family Dollar for $74.50 a Share
Tweet TWEET

Growing Dividends, Acquisitions, Awards for Innovation, Financial Grants, and New Appointments - Research Report on Medtronic,

Growing Dividends, Acquisitions, Awards for Innovation, Financial Grants, and
 New Appointments - Research Report on Medtronic, Wright, Sirona, Align, and
                                     MAKO

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, June 25, 2013

NEW YORK, June 25, 2013 /PRNewswire/ --

Today, Wall Street Reports announced new research reports highlighting
Medtronic, Inc. (NYSE: MDT), Wright Medical Group, Inc. (NASDAQ: WMGI), Sirona
Dental Systems, Inc. (NASDAQ: SIRO), Align Technology, Inc. (NASDAQ: ALGN),
and MAKO Surgical Corp. (NASDAQ: MAKO). Today's readers may access these
reports free of charge - including full price targets, industry analysis and
analyst ratings - via the links below.

Medtronic,Inc. Research Report

On June 20, 2013, the Board of Directors of Medtronic, Inc. (Medtronic)
approved an 8% increase in the Company's cash dividend, raising the quarterly
amount to $0.28 per share of Medtronic's common stock, resulting in an annual
amount of $1.12 per share. Medtronic reported that the dividend increase
brings the Company's dividend yield to 2.2% and expected FY 2014 dividend
payout ratio to approximately 30%. The 8% dividend increase marks Medtronic's
36^th consecutive year of increased dividend payments. The Company stated that
the dividend will be paid on July 26, 2013, to shareholders of record as of
July 5, 2013. Further, the Board of Directors also approved an increase in the
Company's Share Repurchase Plan and authorized the Company to purchase 80
million shares of its common stock, representing an approximately 8% of
Medtronic's total basic shares of common stock outstanding. The Full Research
Report on Medtronic, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.wsreports.com/r/full_research_report/b199_MDT]

--

Wright Medical Group,Inc. Research Report

On June 19, 2013, Wright Medical Group, Inc. (Wright) announced a definitive
agreement under which MicroPort Medical B.V. (MicroPort) will acquire Wright's
OrthoRecon business for a price of $290 million. The deal is expected to close
by the end of Q3 2013 or by early Q4 2013. OrthoRecon business consists of hip
and knee implant products which generated global revenue of approximately $269
million in 2012. According to industry research, the global hip and knee
reconstruction market was estimated to be worth approximately $14 billion in
2012. The research also indicated that the China hip and knee implant market
is growing at approximately 17% per year and is estimated to be worth
approximately $1.3 billion by 2018. After closing of the transaction, Wright
stated that the OrthoRecon business will continue to be headquartered in
Arlington, Tennessee and that Ted Davis, current President of Wright's
OrthoRecon business, will lead the MicroPort Orthopedic business. The Full
Research Report on Wright Medical Group, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.wsreports.com/r/full_research_report/1f8a_WMGI]

--

Sirona Dental Systems,Inc. Research Report

On June 3, 2013, Sirona Dental Systems, Inc. (Sirona) announced that its CEREC
Omnicam was awarded the most innovative product in dentistry at the recently
held Clinical Innovations Conference. The award was presented by Mash Seriki,
CEO of Healthcare Learning Company Ltd. Sirona reported that the features of
CEREC Omnicam that stand out include its ability to support video streaming,
to digitize the structures of the jaw in their natural color, and the
non-requirement of powder coating of the tooth surfaces. Sirona further stated
that the CEREC Omnicam demonstrates the Company's power of innovation. The
Full Research Report on Sirona Dental Systems, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.wsreports.com/r/full_research_report/04e6_SIRO]

--

Align Technology,Inc. Research Report

On June 19, 2013, Align Technology, Inc. (Align) announced that it has awarded
$220,000 in new funding to five universities in North America and seven
international universities for projects seeking to better understand
orthodontic treatment with clear aligners and use of orthodontic scanners. "We
are pleased to see continued and growing interest in our research awards
program - the number of applications we received this year was substantially
greater than received in previous years," said John Morton, Director of
Research and Technology at Align. "Align recognizes that university research
is fundamental and vital to improving dental and orthodontic care, and we are
excited about the research to be conducted as part of these grants." Dr. Mitra
Derakhshan, Director of Clinical International at Align, commented, "The
growth of Invisalign in the European and other international markets is a
direct reflection of the investment Align is making in those markets, a key
component of which is the university research program." The Full Research
Report on Align Technology, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.wsreports.com/r/full_research_report/67be_ALGN]

--

MAKO Surgical Corp. Research Report

On June 3, 2013, MAKO Surgical Corp. (MAKO) announced the appointment of Ian
Dawson to the position of Senior Vice President of Marketing. Dawson assumes
the responsibility for the Company's commercial marketing activities, which
were formerly supervised by Ivan Delevic, who is transitioning to the position
of Senior Vice President of Corporate Development for MAKO. As per the
Company, Dawson and Delevic will report to Maurice R. Ferré, M.D., President
and CEO of MAKO. Ian Dawson has over 25 years of experience in marketing, with
the majority of his experience in the medical device field. Till recently, he
served as Vice President of North America Marketing for Smith & Nephew
Advanced Wound Management from June 2008 through May 2013. "Based on his
impressive background and experience in orthopedics, Ian will be a valuable
addition to the MAKO team," commented Dr. Ferré. The Full Research Report on
MAKO Surgical Corp. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.wsreports.com/r/full_research_report/7865_MAKO]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE Wall Street Reports

Contact: WSReports.com Phone #: +1-310-496-8071 (North America)